Drugs Affecting the Central & Autonomic Nervous System

Overview of the Nervous System

  • The Nervous System is divided into two primary divisions:   - Central Nervous System (CNS): Includes the Brain and the Spinal cord.   - Peripheral Nervous System: Divided into the Somatic nervous system (affecting skeletal muscle) and the Autonomic nervous system.
  • The Autonomic Nervous System is categorized into two functional branches:   - Parasympathetic (Cholinergic): Mediated by the neurotransmitter Acetylcholine (AChACh).   - Sympathetic (Adrenergic): Mediated by the neurotransmitter Norepinephrine (NENE). Receptors include AlphaAlpha (11, 22) and BetaBeta (11, 22).

Autonomic Nervous System (ANS) Responses

  • Parasympathetic Nervous System (PNSPNS): Known as the "Rest and Digest" Response.   - Eyes: Constricts pupils.   - Salivary Glands: Stimulates salivation.   - Heart: Slows heartbeat.   - Lungs: Constricts bronchi.   - Stomach: Stimulates digestion.   - Liver: Stimulates bile release.   - Intestines: Stimulates peristalsis and secretion.   - Bladder: Contracts bladder.   - Anatomical components involved: Medulla Oblongata, Vagus Nerve, Ganglion.
  • Sympathetic Nervous System (SNSSNS): Known as the "Fight or Flight" Response.   - Eyes: Dilates pupils.   - Salivary Glands: Inhibits salivation.   - Heart: Accelerates heartbeat.   - Lungs: Dilates bronchi.   - Stomach: Inhibits digestion.   - Liver: Stimulates glucose release.   - Kidneys: Stimulates epinephrine and norepinephrine release.   - Intestines: Inhibits peristalsis and secretion.   - Bladder: Relaxes bladder.   - Anatomical components involved: Solar Plexus, Chain of Sympathetic Ganglia.

Neurotransmission and Receptor Mechanisms

  • Neurotransmitters: These are chemical substances that enable messages to be transmitted by crossing a synapse. A transmitter can either excite or inhibit a physiological response at a receptor site through:   - Receptor binding.   - Reuptake.   - Metabolism.
  • Activation of the SNSSNS (5/19/20265/19/2026):   - Direct: The drug itself attaches to the receptor and mimics the neurotransmitter.   - Indirect: Causes the release of the neurotransmitter from the pre-synaptic cleft, which then attaches to the receptor.   - Mixed: A combination of both direct and indirect mechanisms.

Sympathetic Nervous System (Adrenergic) Receptors

  • Adrenergic Receptors receive catecholamines/neurotransmitters (norepinephrine and epinephrine) at specific body sites:   - Alpha1Alpha\,1: Responsible for vasoconstriction, decreased Gastrointestinal (GIGI) and bladder motility, mydriasis (pupil dilation), decreased secretions, ejaculation, uterine contractions, and glycogenolysis.   - Alpha2Alpha\,2: Located on the presynaptic nerve; functions to inhibit the SNSSNS response.   - Beta1Beta\,1: Primarily affects the heart, causing increased heart rate, contraction, and conduction.   - Beta2Beta\,2: Causes bronchodilation, uterine relaxation, glycogenolysis, and decreased GIGI motility.
  • Dopaminergic Receptors: Respond to the catecholamine dopamine.   - Increases blood flow to the brain, heart, kidneys, and viscera.   - At high doses, these receptors cause vasoconstriction.

Parasympathetic Nervous System (Cholinergic) Receptors

  • Cholinergic Receptors receive the neurotransmitter acetylcholine (AChACh):   - Muscarinic: Increases GIGI and bladder motility, increases secretions, constricts pupils (miosis), causes bronchoconstriction, and decreases heart rate, contraction, and conduction.   - Nicotinic receptors.

Rationales for Receptor Selectivity and Drug Actions

  • Receptor Selectivity: This allows drugs to alter biological activity at specific receptors without affecting others, resulting in fewer side effects and a more therapeutic outcome.
  • Agonists: Drugs that activate receptors.
  • Antagonists: Drugs that inhibit or block receptor activation.
  • General Pharmacological Actions:   - Increase or decrease neurotransmitter synthesis.   - Promote or inhibit the release of neurotransmitters.   - Activate receptors by binding (agonists).   - Block activation of receptors (antagonists).   - Block or promote neurotransmitter reuptake.   - Inactivate or promote enzymes that metabolize neurotransmitters.

Adrenergic Agonists (Sympathomimetics)

  • Mechanism of Action: These drugs mimic the actions of norepinephrine (NENE), epinephrine (EpiEpi), and dopamine on Alpha1Alpha\,1, Alpha2Alpha\,2, Beta1Beta\,1, Beta2Beta\,2, and dopaminergic receptors.
  • Physiological "Fight or Flight" Effects: Increased visual acuity, alertness, and muscle strength.
  • Pharmacokinetics: Characterized by a rapid onset and a shorter half-life.
  • Clinical Indications:   - Respiratory: Asthma and bronchitis (via Beta2Beta\,2 bronchodilation); Example: Albuterol (Ventolin).   - Nasal Congestion: Vasoconstriction of nasal arterioles (via Alpha1Alpha\,1); Example: Phenylephrine (Neo-Synephrine).   - Ophthalmic: Conjunctival congestion, glaucoma, and mydriasis for eye exams (via Alpha1Alpha\,1 or Beta2Beta\,2); Example: Epinephrine (Adrenalin).   - Cardiovascular: Heart failure, shock, and surgery (vasoactive/cardioselective effects via Alpha1Alpha\,1, Beta1Beta\,1, Beta2Beta\,2, and dopaminergic receptors).     - Dobutamine (Dobutrex).     - Dopamine (Intropin).     - Norepinephrine (Levophed).     - Midodrine (ProAmatine): Specifically treats hypotension.     - Epinephrine (Adrenalin): Emergency use for anaphylactic shock.

Adrenergic Agonist Side Effects and Considerations

  • Side Effects:   - CNSCNS Stimulation: Headache (HAHA), restlessness, insomnia, etc.   - Cardiovascular: Chest pain, vasoconstriction, Hypertension (HTNHTN), tachycardia, palpitations, and dysrhythmias.   - Other: Sweating, nausea/vomiting, muscle cramps, and decreased urinary output.
  • Warning: Monitor for IV infiltration to minimize tissue necrosis from leakage.
  • Geriatric Considerations (5/19/20265/19/2026):   - Decreased efficiency of the heart; stress, heat, and BetaBeta agonists can lead to HTNHTN.   - Decreased baroreceptor sensitivity can lead to orthostatic hypotension.

Nursing Management for Adrenergic Agonists

  • Nursing Activities:   - Collect a thorough health history and physical assessment.   - Monitor Blood Pressure (BPBP), Heart Rate (HRHR), breath sounds, peripheral pulses, skin color, capillary refill, and mental status.   - Assess for sensitivity to light, nausea, constipation, and urinary output.   - Always use an IV pump and assess the IV site frequently.
  • Patient Education:   - Wear Medic-Alert bracelets.   - Instruction on equipment use and prevention measures for respiratory patients.

Adrenergic Antagonists (Sympatholytics)

  • Mechanism of Action: These drugs "lyse" or inhibit SNSSNS stimulation by blocking adrenergic receptors.   - Alpha-blockers: Inhibit Alpha1Alpha\,1 receptors.   - Beta-blockers: Inhibit Beta1Beta\,1 and/or Beta2Beta\,2 receptors.
  • Alpha 1 Blockers:   - Action: Blocks the typical SNSSNS vasoconstriction response, leading to vasodilation.   - Indications:     - HTNHTN: Doxazosin (Cardura) causes arterial and venous dilation.     - Benign Prostatic Hyperplasia (BPHBPH) and Urinary Obstruction: Tamsulosin (Flomax) decreases resistance to urinary outflow in males.     - Tissue Necrosis: Phentolamine (Regitine), a potent vasodilator, is used for extravasation of IV alpha adrenergics.   - Side Effects: Severe hypotension (leading to falls or passing out) and orthostatic hypotension.   - Nursing Activities: Assess BPBP while sitting and standing; assess apical HRHR for 1minute1\,minute.   - Education: Stand slowly; avoid excessive heat, exercise, and alcohol.

Beta-Adrenergic Blockers

  • Functional Specificity:   - Beta1Beta\,1 Blockers: Affect the heart; slow HRHR, conduction, and contractility.   - Beta2Beta\,2 Blockers: Affect the lungs; block bronchodilation, narrowing airways and increasing shortness of breath.
  • Indications: Angina, Myocardial Infarction (MIMI), dysrhythmias, HTNHTN, Heart Failure (HFHF), and migraine headaches.   - Carvedilol (Coreg).   - Metoprolol (Lopressor).   - Propranolol (Inderal): Noted for lipophilicity, allowing it to enter the CNSCNS easily.
  • Contraindications:   - Drug allergies, Heart block, slow HRHR, low BPBP, pregnancy, pulmonary disease, and caution in diabetics.
  • Side Effects:   - Bradycardia, decreased cardiac output/hypotension, bronchoconstriction, and hypoglycemia.

Nursing Management for Beta Blockers

  • Nursing Activities:   - Monitor BPBP and apical HRHR for 1minute1\,minute.   - Assess breath sounds.
  • Education Provided to Clients:   - Do not abruptly discontinue taking medications.   - Monitor daily weights.   - Prevent constipation by increasing fiber and fluids.   - Be aware the drug may cause depression and possible sexual dysfunction.   - Avoid excessive heat, exercise, and alcohol.   - Consider wearing a Medic-Alert bracelet.

Cholinergic Agonist Drugs (Parasympathomimetics)

  • Mechanism of Action: Mimic the neurotransmitter acetylcholine (AChACh) at muscarinic and nicotinic receptors.
  • "Rest and Digest" Response (5/19/20265/19/2026):   - Increased GIGI motility and contraction of the bladder.   - Constriction of the pupil (miosis).   - Decreased heart rate and dilation of blood vessels.   - Constriction of the bronchioles.
  • Direct-Acting Cholinergics:   - Indications: Glaucoma, eye surgery, xerostomia (dry mouth), urinary retention, and GIGI/bladder atony.   - Bethanechol (Urecholine).
  • Indirect-Acting Cholinergics (Acetylcholinesterase inhibitors):   - Indications: Myasthenia gravis (rapid weakness of voluntary muscles) and Alzheimer’s (decreased AChACh levels).   - Pyridostigmine (Mestinon) for Myasthenia gravis.   - Donepezil (Aricept) and Memantine (Namenda) for Alzheimer’s.
  • Contraindications:   - Drug allergy, GIGI or GUGU obstruction, gastric ulcers, bradycardia, hypotension, and pulmonary disorders.

Side Effects and Nursing Management for Cholinergic Agonists

  • Side Effects: Hypotension, bradycardia, syncope, diarrhea, blurred vision, difficulty breathing, and urinary frequency.
  • Toxicity (Cholinergic Crisis): Identified by the acronym SLUDGE:   - Salivation.   - Lacrimation.   - Urinary incontinence.   - Diarrhea.   - GIGI cramps.   - Emesis.
  • Nursing Activities:   - Post-surgery: Walk the patient, provide high fiber foods and hydration.   - Monitor for urinary output, bowel movements (BMBM), increased muscle strength, and improved memory.   - Assess lung sounds and vital signs.   - Administer drugs with meals to reduce GIGI upset.   - Assist with walking, dressing, and toileting.
  • Patient Education:   - Avoid abrupt withdrawal of meds.   - Change positions slowly.   - Connect with community resources (Alzheimer’s support, Meals on Wheels, prescription assistance).

Anticholinergic Drugs (Antagonists)

  • Action: Parasympatholytic; inhibits the rest and digest response. Competitively blocks AChACh at muscarinic receptors.
  • Physiological Responses (Dose Dependent):   - Heart: Blocks slowing; increases HRHR, conduction, and contraction.   - Lungs: Blocks bronchoconstriction; results in bronchodilation.   - GIGI Tract: Blocks increased motility; results in decreased motility.   - Bladder: Blocks bladder emptying; results in bladder retention.   - Eye: Blocks pupil constriction; results in dilation.   - Glands: Blocks secretions; results in decreased secretions.   - CNSCNS: Low dose results in decreased muscle rigidity/tremors; high dose results in drowsiness, disorientation, and hallucinations.
  • Indications:   - Parkinson's and Extrapyramidal symptoms from antipsychotic drugs.   - Eye exams.   - Irritable bowel and diarrhea: Dicyclomine (Bentyl).   - Incontinence and neurogenic bladder: Oxybutynin (Ditropan).   - Bradycardia and heart blocks: Atropine (AtroPen).   - Asthma, bronchitis, and emphysema.   - Reducing secretions (mouth, nose, bronchi) for common colds or surgery: Glycopyrrolate (Robinul).
  • Side Effects: Dry mouth, blurred vision, urinary retention, constipation, and tachycardia.

Nursing Management for Anticholinergic Drugs

  • Nursing Activities (5/19/20265/19/2026):   - Monitor patterns of bowel movements and urinary output.   - Monitor heart rate.   - Prevent constipation.   - Oral Care: Provide oral care; suggest chewing gum or sucking on hard candy; ensure fluids are available.   - Dermal Patch: Apply to dry, non-hairy, non-irritated area; rotate sites.   - Eye Drops: Apply light pressure to the inner canthus for 3060seconds30-60\,seconds; advise wearing sunglasses in light.
  • Patient Education:   - Avoid extreme heat and exercise.   - Drugs may cause drowsiness.